Explorer les evidences

0,55 episodes_per_person_yearIn the 14 months after the first dose of vaccine, the incidence of first episodes of clinical malaria in the first 6000 children aged 5 to 17 months was 0.55 episodes per person-year in the control group.

Burkina Fasopaludismepublié 2011The New England journal of medicineeurope_pmcdocument de 7 observationsDOI 10.1056/nejmoa1102287

46 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of approximately 46% in children aged 5–17 months.

Burkina FasopaludismeHAL · Unilimdocument de 39 observations

0,4 proportionThe kdr frequency varied from 0.4 to 0.97 in Anopheles gambiae populations from the Sudanian region of Burkina Faso from August to October 2006.

Burkina Fasopaludismeobservé August to October 2006publié 2009Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 5 observations

1,6 odds_ratioThe haplotype GGC is associated with increased risk of HIV-1 infection with an odds ratio of 1.6 [1.1–2.3] and p-value < 0.05.

Burkina FasoVIH/sidapublié 2016PloS oneeurope_pmcdocument de 4 observations

0,29 odds_ratioIn Burkina Faso, the odds of malaria were lower 1 month post-SMC administration, with an odds ratio of 0.29, after controlling for seasonal factors, age, sex, net use and other variables.

Burkina Fasopaludismepublié 2022BMJ global healthPubMeddocument de 8 observations

Full susceptibility to organophosphates was observed in Vallée du Kou (VK).

Burkina Fasopaludismepublié 2013Geneeurope_pmcdocument de 6 observations

71,3 %The prevalence of Pfdhfr mutation N51I was 71.3% among 101 genotyped samples.

Burkina Fasopaludismeobservé 2010publié 2017Malaria journaleurope_pmcdocument de 10 observations

1,29 %In Sector 10, the morbidity rate for severe malaria among people over 5 years of age was 1.29% in 2022.

Burkina Fasopaludismeobservé 2022HAL · Unilimdocument de 110 observations

100 %All 135 tested Plasmodium falciparum isolates were susceptible to quinine in Bobo-Dioulasso, Burkina Faso, during July to November 1997.

Burkina Fasopaludismeobservé July to November 1997publié 2001Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 4 observations

56,7 %The prevalence of HBV was 56.7% among HIV-1 positive patients in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublié 2016BMC infectious diseaseseurope_pmcdocument de 4 observations

12,8 %The prevalence of hepatitis B virus infection in Burkina Faso decreased from 12.80% between 1996 and 2001 to 11.11% between 2012 and 2017.

Burkina Fasohépatite Bobservé 1996–2001publié 2018BMC public healtheurope_pmcdocument de 12 observationsDOI 10.1186/s12889-018-5432-7

0,6 proportionThe kdr frequency in the M form of Anopheles gambiae increased to 0.6 in Burkina Faso compared to the 2000 survey.

Burkina Fasopaludismeobservé 2000publié 2009Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 5 observations

53 %The positive predictive value for fever was 53% among pregnant women with suspected clinical malaria.

Burkina Fasopaludismepublié 2013Malaria journaleurope_pmcdocument de 9 observations

20 %20% of infants experienced the first clinical malaria episode before 6 months of age in a birth cohort of 734 infants in Nanoro health district, rural Burkina Faso.

Burkina Fasopaludismepublié 2018Malaria journaleurope_pmcdocument de 3 observations

84,6 %Among pregnant women aged 18–25 years in Ouagadougou, Burkina Faso, the prevalence of anti-rubella IgG was 84.6%.

Burkina Fasorubellapublié 2012Asian Pacific journal of tropical medicineeurope_pmcdocument de 8 observations

8,69 %The overall seroprevalence rate of HCV among blood donors in Burkina Faso was 8.69%.

Burkina Fasohépatite Cpublié 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument de 9 observations

2,4 %All-cause mortality was higher in RTS,S/AS01-vaccinated versus control girls (2.4% vs 1.3%, all ages).

Burkina Fasopaludismepublié 2019Human vaccines & immunotherapeuticseurope_pmcdocument de 7 observations

96,4 %In 2016, Burkina Faso reported a monthly Ministry of Health seasonal malaria chemoprevention coverage rate of 96.4%.

Burkina Fasopaludismeobservé 2016HAL · Unilimdocument de 110 observations

26,9 %Mosquito density was 26.9% (19,656/73,101) in year 3 of the study.

Burkina FasopaludismeHAL · Unilimdocument de 87 observations

72 %Among 99 HBV strains from HBsAg positive candidate blood donors in Ouagadougou, HBV genotype E had a prevalence of 72%.

Burkina Fasohépatite Bpublié 2016Journal of medical virologyeurope_pmcdocument de 4 observations

37 %Gastro-intestinal infections accounted for 37.0% of non-malaria infections in febrile children under 5 years of age in rural Burkina Faso.

Burkina Fasogastro-intestinal infectionspublié 2018Infectious diseases of povertyeurope_pmcdocument de 11 observations

1,75 %Vertical transmission of HIV was 1.75% (2/114) among mothers under prophylaxis.

Burkina FasoVIH/sidapublié 2015Global health actioneurope_pmcdocument de 5 observations

1,9 %In Banfora, the sporozoite infection rate (SIR) was 1.9% in year 3.

Burkina Fasopaludismeobservé year 3HAL · Unilimdocument de 87 observations

121 EU/mLAn anti-circumsporozoite antibody titre of 121 EU/mL was estimated to prevent 50% of infections.

Burkina Fasopaludismepublié 2015The Lancet. Infectious diseaseseurope_pmcdocument de 5 observations

42,9 %In nonpregnant women, parasitemia prevalence was 42.9% in the iron supplementation group and 39.2% in the control group.

Burkina Fasopaludismepublié 2018The Journal of infectious diseaseseurope_pmcdocument de 7 observations